Clone-level multi-modal prediction of tumour drug response
Quentin Duchemin, Daniel Trejo Banos, Anne Bertolini, Pedro Ferreira, Rudolf Schill, Matthias Lienhard, Rebekka Wegmann, Berend Snijder, Daniel Johannes Stekhoven, Niko Beerenwinkel, Franziska Singer, Guillaume Obozinski, Jack Kuipers
This paper introduces scClone2DR, a framework predicting tumour drug response at the clone level using single-cell DNA/RNA sequencing and drug-screening data, showing improved accuracy in identifying clonal sensitivities and resistance.
bioRxiv · May 11, 2026 · PreprintCancer Biology